Macquarie Group LTD Coherus Bio Sciences, Inc. Transaction History

Macquarie Group LTD

$80.3 Billion
Q1 2025

A detailed history of Macquarie Group LTD transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 899,999 shares of CHRS stock, worth $872,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares

899,999

Previous 899,999 -0.0%

Holding current value

$872,999

Previous $1.24 Million 41.34%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.02 - $3.14 $505,000 - $785,000	250,000 Added 38.46%	899,999 $2.15 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $3.85 $240,726 - $582,890	151,400 Added 30.37%	649,999 $2.16 Million
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $256,560 - $373,864	68,599 Added 15.95%	498,599 $1.86 Million
Q4 2022 Feb 21, 2023	SELL	$5.69 - $10.07 $3,362 - $5,951	-591 Reduced 0.14%	430,000 $3.41 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $5,621 - $10,874	-784 Reduced 0.18%	430,591 $4.15 Million
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $5,349 - $7,935	-371 Reduced 0.09%	431,375 $6.3 Million
Q2 2020 Aug 11, 2020	BUY	$14.43 - $19.16 $25,194 - $33,453	1,746 Added 0.41%	431,746 $7.71 Million
Q1 2019 May 15, 2019	SELL	$8.38 - $15.5 $2,514 - $4,650	-300 Reduced 0.07%	430,000 $5.87 Million
Q3 2018 Nov 15, 2018	SELL	$14.45 - $20.25 $39,015 - $54,675	-2,700 Reduced 0.62%	430,300 $7.1 Million
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $133,250 - $226,850	13,000 Added 3.1%	433,000 $6.06 Million
Q1 2018 May 11, 2018	BUY	$9.1 - $13.7 $215,670 - $324,690	23,700 Added 5.98%	420,000 $4.64 Million
Q4 2017 Feb 15, 2018	BUY	$8.35 - $14.4 $887,605 - $1.53 Million	106,300 Added 36.66%	396,300 $3.49 Million
Q3 2017 Nov 08, 2017	BUY	$11.1 - $14.5 $3.22 Million - $4.21 Million	290,000	290,000 $3.87 Million

Others Institutions Holding CHRS

# of Institutions

120

Shares Held

64.4M

Call Options Held

96.6K

Put Options Held

65.3K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $75.4M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Coherus Bio Sciences, Inc. Transaction History